I went on the Business of Biotech podcast to tell the story of Bioptic — how a bunch of software nerds ended up building a next-gen drug discovery company.
We talk about:
- How we use generative AI and ultra-fast screening to find new drugs
- The awkward marriage of tech and biotech (spoiler: it's not always smooth)
- Why access to data is the real bottleneck
- And what’s coming next as we go deeper into solving drug discovery’s hardest problems
It’s honest. It's practical. And if you’re working at the messy edge of science and software, I think you’ll relate.
🎧 Full episode here:
https://www.youtube.com/watch?v=4mZxkA7_Cc8&ab_channel=LifeScienceConnect
– Andrey Doronichev
%20(1).png)
